{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T14:40:59Z","timestamp":1776436859042,"version":"3.51.2"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chronic Inflammatory Response Syndrome (CIRS), a complex condition triggered by environmental exposures such as mold toxins, remains challenging to treat effectively. This case study documents the incidental findings of hyperbaric oxygen therapy (HBOT) as a potential therapeutic intervention for CIRS. A 60-year-old female patient with persistent symptoms and abnormal laboratory markers underwent 40 shallow dive HBOT sessions over 10 weeks. Clinical evaluations included symptom scoring, visual contrast sensitivity (VCS) testing, and biomarker analysis, with pre-treatment tests conducted via Quest Diagnostics and post-treatment tests via LabCorp. Results demonstrated significant improvements: resolution of all 22 reported symptoms, normalization of VCS scores (from 68% to 93%), and notable reductions in inflammatory biomarkers, including TGF-\u03b21 and MMP-9. This case illustrates HBOT\u2019s ability to modulate systemic inflammation, improve neurocognitive outcomes, and enhance recovery in patients with complex environmental illnesses. While limited to a single-patient design, this study underscores the need for extensive quantitative research to validate HBOT\u2019s efficacy in managing CIRS and similar conditions.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1564788","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T05:25:13Z","timestamp":1754371513000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case Report: Low pressure hyperbaric oxygen therapy as a potential alternative treatment for chronic inflammatory response syndrome: a case study with notable improvements in fatigue, cognition, and testing"],"prefix":"10.3389","volume":"16","author":[{"given":"Kristen L.","family":"Coletti Giesler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1191\/0748233705th240oa","article-title":"Biotoxin-associated illness: Multiple-system, multisymptom illness derived from exposure to biologically produced toxins","volume":"21","author":"Shoemaker","year":"2005","journal-title":"Toxicol Ind Health"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7231435","article-title":"Chronic Inflammatory Response Syndrome (CIRS): Definition, mechanisms, and treatment strategies","volume":"2016","author":"Shoemaker","year":"2016","journal-title":"J Environ Public Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12974-023-02985-6","article-title":"Oxygen therapy attenuates neuroinflammation after spinal cord injury","volume":"20","author":"Sunshine","year":"2023","journal-title":"J Neuroinflamm"},{"key":"B4","volume-title":"Toxic: Heal your body from mold toxicity, Lyme disease, multiple chemical sensitivities, and chronic environmental illness","author":"Nathan","year":"2018"},{"key":"B5","volume-title":"Break the mold: 5 tools to conquer mold and take back your health","author":"Crista","year":"2015"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10096-010-0937-8","article-title":"Improvement of attention span and reaction time with hyperbaric oxygen treatment in patients with toxic injury due to mold exposure","volume":"30","author":"Ezra","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4103\/2045-9912.279978","article-title":"Hyperbaric oxygen therapy for mild traumatic brain injury persistent postconcussion syndrome: A randomized controlled trial","volume":"10","author":"Harch","year":"2020","journal-title":"Med Gas Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-018-0843-2","article-title":"Hyperbaric oxygen alleviates the inflammatory response induced by LPS through inhibition of NF-\u03baB\/MAPKs-CCL2\/CXCL1 signaling pathway in cultured astrocytes","volume":"41","author":"Liu","year":"2018","journal-title":"Inflammation"},{"key":"B9","volume-title":"The sensitive patient\u2019s guide to healing: Personalized strategies for chronic environmental illness","author":"Nathan","year":"2024"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2010.01.009","article-title":"Structural brain abnormalities in patients with inflammatory illness acquired following exposure to water-damaged buildings: A volumetric MRI study using NeuroQuant","volume":"32","author":"Shoemaker","year":"2010","journal-title":"Neurotoxicology Teratology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3233\/RNN-190959","article-title":"Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients: A retrospective analysis","volume":"38","author":"Hadanny","year":"2020","journal-title":"Restorative Neurol Neurosci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.29252\/.25.6.416","article-title":"Hyperbaric oxygen therapy increases brain-derived neurotrophic factor as well as decreases systemic immune-inflammatory index and systemic inflammatory response index in autism spectrum disorder","volume":"25","author":"Biutifasari","year":"2021","journal-title":"Iranian Biomed J"},{"key":"B13","article-title":"New hyperbaric oxygen therapy protocol can improve cognitive function of older adults","year":"2020","journal-title":"Aging"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1564788\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T05:25:14Z","timestamp":1754371514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1564788\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":13,"alternative-id":["10.3389\/fimmu.2025.1564788"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1564788","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"article-number":"1564788"}}